LENSRXLAB Raises $830,000 to Revolutionize Diabetic Eye Care.

A Mission Backed by Investment.

LENSRXLAB has raised $830,000 in seed funding to improve diabetic vision care innovation and healthcare delivery solutions. This funding will support the development of two B2B platforms and advanced lenses tailored for people with diabetes. The company aims to simplify access to vision care and reduce complications linked to diabetic eye conditions.

Founders Focused on Impact.

The company was co-founded by Anthony B. Miles and Dr. Chelise Firmin. Anthony is a U.S. Navy veteran with deep roots in community service and business strategy. Dr. Firmin is an optometrist committed to improving health equity through clinical care and innovation. Together, they lead a mission to close the gap in diabetic vision care across underserved populations.

Building Digital Healthcare Platforms.

The funding will be used to create two digital platforms focused on supplemental vision benefits. These platforms will serve hospitals, insurers, employers, and diabetic care centers across the healthcare system. They will offer ready-to-use eyewear packages designed to simplify distribution and increase patient satisfaction. The goal is to make diabetic eyewear more accessible, efficient, and affordable.

Introducing DiaVista Lens Technology.

One of the company’s key innovations is the DiaVista lens, created specifically for diabetic patients. These lenses feature seven protective layers that block harmful UV and infrared light. DiaVista technology reduces eye strain and helps prevent long-term damage from exposure to harsh light. Lenses will be distributed through global partnerships with B2B providers and healthcare systems.

Expanding with a New Facility.

LENSRXLAB plans to open a manufacturing facility in Philadelphia to support growing demand. The facility will boost production, create jobs, and strengthen local healthcare collaborations. It reflects the company’s commitment to community development and sustainable growth.

Social Impact and Community Care.

LENSRXLAB is also launching a voucher program to offer free eyewear to seniors and low-income diabetic patients. Donors and companies invested in health equity will fund this initiative. The program ensures that cost never stands in the way of proper vision care.

Future-Ready Innovations.

The company is developing lenses that block blue light for people who spend hours on digital devices. In addition, it will launch “LENS LEGENDS,” an animated series to educate families on eye health. This creative campaign brings fun and awareness to an often-overlooked health issue.

A Clearer Future Ahead.

LENSRXLAB aims to reshape diabetic eye care worldwide with strong funding and a clear purpose. Their vision is simple—make advanced, affordable vision care accessible to everyone who needs it.

 

Must Read

Eargo and hearX Merge to Form LXE Hearing: A Strategic Step in Hearing Health Innovation.

In a significant move within the medical device industry,...

Global Surgical Equipment Market to Total $56.6 Billion by 2029.

Market Overview. The global surgical equipment market is anticipated to...

Spinal Fusion Device Market to Surpass $11 Billion by 2033

Spinal fusion device market growth The worldwide Spinal fusion device...

Montana’s Healthcare Worker Shortage: Legislative Action to Fill the Gap.

Montana healthcare worker shortage, impacting hospitals, clinics, and long-term...

FDA Approves Vutrisiran to Treat ATTR-CM- New Treatment Seeks to Minimize Risks of Heart Failure in Patients.

FDA approval Vutrisiran ATTR-CM treatment for the treatment of...

Topics

Global Surgical Equipment Market to Total $56.6 Billion by 2029.

Market Overview. The global surgical equipment market is anticipated to...

Beyond Medications: How Diet Aids Skin Health.

Medications control skin diseases, but diet is important as...

The Future of Dermatology: How Telehealth is Revolutionizing Patient Care.

With the rise of teledermatology services, patients can now...

Mounjaro: A New Breakthrough for Weight Loss in Non-Diabetic Individuals

Mounjaro for Weight Loss in Non-Diabetics Mounjaro for weight loss...

Johnson & Johnson MedTech Reveal Innovative Orthopaedic Breakthroughs at AAOS 2025.

At the American Academy of Orthopaedic Surgeons (AAOS) 2025...

The Emerging Risk of Fungal Infections: A Call for Immediate Action.

Fungal infections are becoming an escalating global health threat,...

Symplr’s Cloud-Based Platform: A Step Towards Smarter Healthcare Operations.

The healthcare sector is evolving every day, with technology...

Study Reveals Genetic Connection Between Obesity in People and Dogs.

Researchers have found a genetic connection between obesity in...

Related Articles

Popular Categories